SARS Coronavirus Vaccine (SARS-CoV)

首次发布于 2007 年 9 月 21 日

Pre-exposure Prophylaxis for SARS-Coronavirus-2

计划入组 1,483 人 · 首次发布于 2020 年 3 月 31 日

Surveillance Among Healthcare Workers for SARS-Coronavirus-2 Infection

计划入组 512 人 · 首次发布于 2022 年 1 月 4 日

SARS-coronavirus vaccine (AlphaVax)

dual viral protease/replication inhibitors (SARS-Coronavirus/Enterovirus infections)

SARS Coronavirus Vaccine(National Institute of Allergy and Infectious Diseases)

Invivyd

United States

Quince Therapeutics

United States

Arbutus Biopharma

United States

SK Bioscience Launches First-in-Class Universal Coronavirus Vaccine Trial, Targeting Entire Sarbecovirus Family

Single Amino Acid Switch Determines Coronavirus Spillover from Bats to Humans

Sunshine Biopharma Launches Generic Amoxicillin in Canada, Targeting $4.9 Billion Global Market